Compare AD & MIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AD | MIR |
|---|---|---|
| Founded | 1983 | 2005 |
| Country | United States | United States |
| Employees | 60 | 3281 |
| Industry | Telecommunications Equipment | Industrial Machinery/Components |
| Sector | Telecommunications | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.3B | 4.5B |
| IPO Year | N/A | N/A |
| Metric | AD | MIR |
|---|---|---|
| Price | $50.60 | $18.25 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 8 |
| Target Price | ★ $55.00 | $27.25 |
| AVG Volume (30 Days) | 166.4K | ★ 3.7M |
| Earning Date | 05-08-2026 | 04-28-2026 |
| Dividend Yield | ★ 69.43% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $33.57 | $23.95 |
| Revenue Next Year | N/A | $7.32 |
| P/E Ratio | $275.77 | ★ $195.00 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $44.03 | $16.84 |
| 52 Week High | $77.13 | $30.28 |
| Indicator | AD | MIR |
|---|---|---|
| Relative Strength Index (RSI) | 52.10 | 43.46 |
| Support Level | $45.91 | $16.98 |
| Resistance Level | $50.66 | $20.70 |
| Average True Range (ATR) | 1.77 | 0.78 |
| MACD | -0.06 | -0.12 |
| Stochastic Oscillator | 21.75 | 24.86 |
Array Digital Infrastructure, formerly US Cellular, sold its regional wireless operations serving about 4.4 million customers to T-Mobile in August 2025. The firm has agreed to sell most of its remaining spectrum licenses; however, it will still retain rights to C-band spectrum in several locations after these deals are closed. Array also owns a 5.5% stake in Verizon Wireless' Los Angeles operations, as well as other smaller wireless partnership interests in Oklahoma and upstate New York. The firm still operates a portfolio of about 4,400 wireless towers.
Mirion Technologies Inc provides products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. The Company manages its operations through two segments: Nuclear & Safety and Medical. The Medical segment improves the quality and safety of cancer care delivery and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense.